Repligen Corp logo


Repligen Corp


Earnings Summary

Net Profits
Net Profit Margins



Repligen Corp’s revenue jumped 46.55% since last year same period to $44.83Mn in the Q1 2018. On a quarterly growth basis, Repligen Corp has generated 7.73% jump in its revenue since last 3-months.

Net Profits:

Repligen Corp’s net profit jumped 12.39% since last year same period to $3.45Mn in the Q1 2018. On a quarterly growth basis, Repligen Corp has generated -71.69% fall in its net profits since last 3-months.

Net Profit Margins:

Repligen Corp’s net profit margin fell -23.31% since last year same period to 7.69% in the Q1 2018. On a quarterly growth basis, Repligen Corp has generated -73.72% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Repligen Corp post its latest quarter earnings

EPS Estimate Current Quarter
EPS Estimate Current Year


EPS Estimate Current Quarter:

Repligen Corp’s earning per share (EPS) estimates for the current quarter stand at 0.69 - a 0.82% jump from last quarter’s estimates.

EPS Estimate Current Year:

Repligen Corp’s earning per share (EPS) estimates for the current year stand at 0.69.

Key Ratios

Key ratios of the Repligen Corp post its Q2 2022 earnings

Earning Per Share (EPS)
Return on Assets (ROA)
Return on Equity (ROE)


Earning Per Share (EPS):

Repligen Corp’s earning per share (EPS) jumped 15.19% since last year same period to 0.91 in the Q2 2022. This indicates that the Repligen Corp has generated 15.19% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Repligen Corp’s return on assets (ROA) stands at 0.06.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Repligen Corp’s return on equity (ROE) stands at 0.09.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %

Company Information

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Repligen Corp
Building 1, Waltham, MA, United States, 02453
Health Technology
Anthony Hunt

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*